With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

Rhythm Technologies announced new research emphasizing the clinical and health-economic advantages of its Zio LTCM system.

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

This study links rare genetic variants to type 2 diabetes risk, emphasizing their role in monogenic diabetes and potential ...

Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...

On World Diabetes Day (November 14) the city’s university has announced it has teamed up with the University of Leeds to ...